table of content
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Liquid Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Liquid Biopsy Overall Market Size
2.1 Global Breast Cancer Liquid Biopsy Market Size: 2023 VS 2030
2.2 Global Breast Cancer Liquid Biopsy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Liquid Biopsy Players in Global Market
3.2 Top Global Breast Cancer Liquid Biopsy Companies Ranked by Revenue
3.3 Global Breast Cancer Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Liquid Biopsy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Breast Cancer Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Liquid Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Liquid Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Breast Cancer Liquid Biopsy Market Size Markets, 2023 & 2030
4.1.2 Circulating Tumor Cells (CTCs)
4.1.3 Cell-Free DNA (CfDNA)
4.1.4 Extracellular Vesicles (EVs)
4.1.5 Other Circulating Biomarkers
4.2 By Type - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Liquid Biopsy Revenue, 2019-2024
4.2.2 By Type - Global Breast Cancer Liquid Biopsy Revenue, 2025-2030
4.2.3 By Type - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Liquid Biopsy Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Laboratories
5.2 By Application - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Liquid Biopsy Revenue, 2019-2024
5.2.2 By Application - Global Breast Cancer Liquid Biopsy Revenue, 2025-2030
5.2.3 By Application - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Breast Cancer Liquid Biopsy Market Size, 2023 & 2030
6.2 By Region - Global Breast Cancer Liquid Biopsy Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Liquid Biopsy Revenue, 2019-2024
6.2.2 By Region - Global Breast Cancer Liquid Biopsy Revenue, 2025-2030
6.2.3 By Region - Global Breast Cancer Liquid Biopsy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Breast Cancer Liquid Biopsy Revenue, 2019-2030
6.3.2 US Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.3.3 Canada Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.3.4 Mexico Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Liquid Biopsy Revenue, 2019-2030
6.4.2 Germany Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4.3 France Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4.4 U.K. Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4.5 Italy Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4.6 Russia Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4.7 Nordic Countries Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.4.8 Benelux Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Liquid Biopsy Revenue, 2019-2030
6.5.2 China Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.5.3 Japan Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.5.4 South Korea Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.5.5 Southeast Asia Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.5.6 India Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Breast Cancer Liquid Biopsy Revenue, 2019-2030
6.6.2 Brazil Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.6.3 Argentina Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Liquid Biopsy Revenue, 2019-2030
6.7.2 Turkey Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.7.3 Israel Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.7.4 Saudi Arabia Breast Cancer Liquid Biopsy Market Size, 2019-2030
6.7.5 UAE Breast Cancer Liquid Biopsy Market Size, 2019-2030
7 Breast Cancer Liquid Biopsy Companies Profiles
7.1 QIAGEN
7.1.1 QIAGEN Company Summary
7.1.2 QIAGEN Business Overview
7.1.3 QIAGEN Breast Cancer Liquid Biopsy Major Product Offerings
7.1.4 QIAGEN Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.1.5 QIAGEN Key News & Latest Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Company Summary
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Major Product Offerings
7.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.2.5 Roche Diagnostics Key News & Latest Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Company Summary
7.3.2 Bio-Rad Laboratories Business Overview
7.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Major Product Offerings
7.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.3.5 Bio-Rad Laboratories Key News & Latest Developments
7.4 Myriad Genetics
7.4.1 Myriad Genetics Company Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Major Product Offerings
7.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.4.5 Myriad Genetics Key News & Latest Developments
7.5 Menarini Silicon Biosystems
7.5.1 Menarini Silicon Biosystems Company Summary
7.5.2 Menarini Silicon Biosystems Business Overview
7.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Major Product Offerings
7.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.5.5 Menarini Silicon Biosystems Key News & Latest Developments
7.6 Genomic Health
7.6.1 Genomic Health Company Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Breast Cancer Liquid Biopsy Major Product Offerings
7.6.4 Genomic Health Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.6.5 Genomic Health Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Major Product Offerings
7.7.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Illumina
7.8.1 Illumina Company Summary
7.8.2 Illumina Business Overview
7.8.3 Illumina Breast Cancer Liquid Biopsy Major Product Offerings
7.8.4 Illumina Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.8.5 Illumina Key News & Latest Developments
7.9 Biocept
7.9.1 Biocept Company Summary
7.9.2 Biocept Business Overview
7.9.3 Biocept Breast Cancer Liquid Biopsy Major Product Offerings
7.9.4 Biocept Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.9.5 Biocept Key News & Latest Developments
7.10 Trovagene
7.10.1 Trovagene Company Summary
7.10.2 Trovagene Business Overview
7.10.3 Trovagene Breast Cancer Liquid Biopsy Major Product Offerings
7.10.4 Trovagene Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.10.5 Trovagene Key News & Latest Developments
7.11 Guardant Health
7.11.1 Guardant Health Company Summary
7.11.2 Guardant Health Business Overview
7.11.3 Guardant Health Breast Cancer Liquid Biopsy Major Product Offerings
7.11.4 Guardant Health Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.11.5 Guardant Health Key News & Latest Developments
7.12 RainDance Technologies
7.12.1 RainDance Technologies Company Summary
7.12.2 RainDance Technologies Business Overview
7.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Major Product Offerings
7.12.4 RainDance Technologies Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.12.5 RainDance Technologies Key News & Latest Developments
7.13 MDx Health
7.13.1 MDx Health Company Summary
7.13.2 MDx Health Business Overview
7.13.3 MDx Health Breast Cancer Liquid Biopsy Major Product Offerings
7.13.4 MDx Health Breast Cancer Liquid Biopsy Revenue in Global Market (2019-2024)
7.13.5 MDx Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
